ClearPoint Neuro, Inc.
General ticker "CLPT" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $409.6M (TTM average)
ClearPoint Neuro, Inc. follows the US Stock Market performance with the rate: 25.6%.
Estimated limits based on current volatility of 4.1%: low 10.29$, high 11.16$
Factors to consider:
- Total employees count: 115 (+7.5%) as of 2024
- Top business risk factors: Economic downturns and volatility, Customer concentration, Manufacturing disruptions, Cybersecurity threats, Acquisition/divestiture risks
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [8.83$, 19.24$]
- 2026-12-31 to 2027-12-31 estimated range: [7.47$, 16.83$]
Financial Metrics affecting the CLPT estimates:
- Positive: with PPE of -15.4 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -6.04 <= 0.07
- Positive: 19.49 < Shareholder equity ratio, % of 28.67 <= 42.60
- Positive: Investing cash flow per share per price, % of 0.16 > -0.65
Short-term CLPT quotes
Long-term CLPT plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $23.95MM | $31.39MM | $36.97MM |
| Operating Expenses | $46.40MM | $51.14MM | $61.13MM |
| Operating Income | $-22.45MM | $-19.75MM | $-24.16MM |
| Non-Operating Income | $0.36MM | $0.83MM | $-1.32MM |
| Interest Expense | $0.00MM | $0.00MM | $2.39MM |
| R&D Expense | $11.71MM | $12.39MM | $13.90MM |
| Income(Loss) | $-22.09MM | $-18.91MM | $-25.48MM |
| Taxes | $0.00MM | $0.00MM | $0.06MM |
| Profit(Loss)* | $-22.09MM | $-18.91MM | $-25.54MM |
| Stockholders Equity | $21.17MM | $25.39MM | $28.02MM |
| Inventory | $7.91MM | $6.86MM | $8.36MM |
| Assets | $42.66MM | $39.19MM | $97.75MM |
| Operating Cash Flow | $-13.72MM | $-8.95MM | $-23.93MM |
| Capital expenditure | $0.72MM | $0.28MM | $0.52MM |
| Investing Cash Flow | $8.95MM | $-0.28MM | $0.61MM |
| Financing Cash Flow | $0.30MM | $6.19MM | $50.18MM |
| Earnings Per Share** | $-0.90 | $-0.70 | $-0.90 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.